Tier 3 · Filer Universe
CNS Pharmaceuticals, Inc.
CNSP · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$5.04
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001729427
Liquidity rank
#5907
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | Not published | Not published | No matching frame |
| Annual diluted EPS | -35.75 | 2025-12-31 | 0001683168-26-002550 |
| Quarterly revenue | Not published | Not published | No matching frame |
| Quarterly diluted EPS | -7.3 | 2026-03-31 | 0001683168-26-003847 |
SEC EDGAR Frames batch generated 2026-07-16T23:27:27.045Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerTMO · Tier 1 peerDHR · Tier 1 peerAMGN · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames